FDA OKs first seasonal flu vaccine made using animal cell cultures

11/20/2012 | Reuters

The FDA has approved the use of Novartis' seasonal influenza vaccine for people ages 18 and older. The vaccine, which will be marketed under the brand name Flucelvax, is the first seasonal flu vaccine produced using animal cell cultures instead of the traditional chicken egg method, which allows for a faster production process.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Education

Job Title Company Location
School District of Philadelphia - Director, Observation and Feedback Coaches Program
School District of Philadelphia
Philadelphia, PA
Research Scientist
NWEA
Portland, OR
Instructional Designer, ESL
Imagine Learning, Inc.
Provo, UT
Account Executive, National Accounts
NWEA
Nationwide, SL_Nationwide
Instructional Specialist
Community Training and Assistance Center
Richmond, VA